For patients already engaged in a comprehensive longevity program that includes metabolic monitoring, MOTS-c fits naturally into the toolkit
Here are some key research findings on GHK-Cu: Collagen production: In a placebo-controlled study, GHK-Cu improved collagen production in 70% of participants, outperforming both vitamin C cream and retinoic acid Skin quality: A 12-week facial cream trial on 71 women with photoaging showed improved skin laxity, clarity, firmness, and increased skin density and thickness Wrinkle reduction: A 2016 study in the Journal of Aging Science found GHK-Cu in nano-carrier formulation reduced wrinkle volume by 31.6% compared to a commercial peptide product Broader effects: Promotes angiogenesis, supports nerve outgrowth, and demonstrates antioxidant and anti-inflammatory activity in cell culture and animal models GHK-Cu can be administered by subcutaneous injection or topical application, with injectable forms offering higher bioavailability

Pharmacies can also bill CPT 90471 directly when they have appropriate enrollment, credentialing, and payer contracts in place (a growing segment of immunization billing, particularly for influenza, COVID-19, and shingles vaccines)
Challenges for research on polyphenols from foods in Alzheimers disease: bioavailability, metabolism, and cellular and molecular mechanisms